Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Trillions.
The item "End-Period-Cash-Flow" stands at 1.92 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Chugai Pharmaceutical Co. Ltd.'s third quarter result of 0.4564 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -8.18 percent compared to it's second quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 0.4564 Trillion JPY for the item "End Period Cash Flow" represents an increase of 12.99 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 1.92 Trillion JPY for the item "End Period Cash Flow" represents an increase of 2.81 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.51 percent compared to the value the year prior.
The 1 year change in percent is 11.51.
The 3 year change in percent is 69.27.
The 5 year change in percent is 165.54.
The 10 year change in percent is 294.62.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - End Period Cash Flow | 905,699,262,464.00 |
![]() | Johnson & Johnson - End Period Cash Flow | 486,508,953,600.00 |
![]() | AbbVie Inc - End Period Cash Flow | 399,570,305,024.00 |
![]() | Roche Holding AG - End Period Cash Flow | 317,433,206,677.55 |
![]() | AstraZeneca PLC - End Period Cash Flow | 280,205,508,085.11 |